Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
- Resource Type
- Article
- Source
- In
Clinical Gastroenterology and Hepatology May 2020 18(5):1152-1160 - Subject
- Language
- ISSN
- 1542-3565